Literature DB >> 2774322

Hemagglutination and hemagglutination inhibition of turkey red blood cells with Mycoplasma hyopneumoniae.

T F Young1, B Z Erickson, R F Ross, Y Wannemuehler.   

Abstract

The ability of Mycoplasma hyopneumoniae to agglutinate RBC was evaluated to develop an in vitro cytadsorption assay. Using swine RBC in a microtitration hemagglutination test, no agglutination or partial agglutination was detected. Comparison of RBC from various other species indicated that improved hemagglutination was obtained with RBC from turkeys. This hemagglutination was detected only when mycoplasma cells used in the assay had been frozen and thawed, heated at 50 C for 30 minutes, or treated with trypsin. Treatment of RBC with trypsin or neuraminidase enhanced hemagglutination. Possible surface lectin activity in M hyopneumoniae was evaluated by use of carbohydrates in a blocking assay; hemagglutination was not inhibited by any of 13 carbohydrates evaluated. Mycoplasma hyopneumoniae convalescent porcine serum and monoclonal antibodies against 2 M hyopneumoniae immunogens of molecular weights of 64,000 and 41,000 inhibited hemagglutination.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2774322

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  4 in total

1.  R1 region of P97 mediates adherence of Mycoplasma hyopneumoniae to swine cilia.

Authors:  F C Minion; C Adams; T Hsu
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Microtiter plate adherence assay and receptor analogs for Mycoplasma hyopneumoniae.

Authors:  Q Zhang; T F Young; R F Ross
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

3.  Glycolipid receptors for attachment of Mycoplasma hyopneumoniae to porcine respiratory ciliated cells.

Authors:  Q Zhang; T F Young; R F Ross
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

4.  Quantitative assessment of Mycoplasma hemadsorption activity by flow cytometry.

Authors:  Luis García-Morales; Luis González-González; Manuela Costa; Enrique Querol; Jaume Piñol
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.